ATP increases its ownership in ALK-Abelló Pursuant to section 28(a) of the Danish Public Companies Act and section 29 of the Danish Securities Trading Act, ALK-Abelló A/S has received notification from ATP (the Labour Market Supplementary Pension Scheme) that ATP and ATP Invest, Hillerød, Denmark, have increased their ownership in ALK-Abelló A/S. ATP and ATP Invest now own 9.09% of the company share capital equivalent to 920,977 shares and 5.00% of the votes. Hørsholm, February 13, 2008 ALK-Abelló A/S Jens Bager President and CEO For further information please contact: Per Plotnikof, Investor Relations, tel. +45 4574 7527
Recommended Reading
-
ALK announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation for EURneffy® 1 mg, the first and only needle-free adrenaline treatment for...
Read More -
Over half (54%) of adults at risk of anaphylaxis admit they have been without their adrenaline auto-injector (AAI) when needed—and nearly 40% do not carry one regularly (n=1,238 ).1HCP survey data...
Read More